Biofil Chemicals Pharmaceuticals Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 36.2 as of 12 Jun 15:30 . The p/e ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 121 to 137.2 over 5 quarters. This represents a CAGR of 10.57% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 66.92 crore to ₹ 98.21 crore over 5 quarters. This represents a CAGR of 35.92% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Biofil Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 7.67 crore as compare to the Dec '25 revenue of ₹ 0.93 crore. This represent the growth of 724.73% The revenue of Procter & Gamble Health Ltd for the Mar '26 is ₹ 374.45 crore as compare to the Dec '25 revenue of ₹ 378.22 crore. This represent the decline of -1% The ebitda of Biofil Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 0.54 crore as compare to the Dec '25 ebitda of ₹ 0.17 crore. This represent the growth of 217.65% The ebitda of Procter & Gamble Health Ltd for the Mar '26 is ₹ 139.59 crore as compare to the Dec '25 ebitda of ₹ 114.82 crore. This represent the growth of 21.57% The net profit of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0.16 crore to ₹ 0.21 crore over 8 quarters. This represents a CAGR of 14.56% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 94.6 crore over 8 quarters. This represents a CAGR of 42.54% The dividend payout of Biofil Chemicals & Pharmaceuticals Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
Later on, the Company was converted into a Public Limited Company on 7 May '92.
The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Biofil Chemicals & Pharmaceuticals Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Biofil Chemicals & Pharmaceuticals Ltd or Procter & Gamble Health Ltd?

Market cap of Biofil Chemicals & Pharmaceuticals Ltd is 58 Cr while Market cap of Procter & Gamble Health Ltd is 10,413 Cr

What are the key factors driving the stock performance of Biofil Chemicals & Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

The stock performance of Biofil Chemicals & Pharmaceuticals Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Biofil Chemicals & Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

As of June 15, 2026, the Biofil Chemicals & Pharmaceuticals Ltd stock price is INR ₹36.2. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹6273.55.

How do dividend payouts of Biofil Chemicals & Pharmaceuticals Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Biofil Chemicals & Pharmaceuticals Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.